Antipsychotics and risk of diabetes in schizophrenia

摘要

Smith et al state that there is increasing concern among clinicians about the association between second-generation antipsychotics and diabetes.[1][1] It is interesting then that while commenting on the lack of systematic reviews and meta-analyses that support this concern, the authors go on to